MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Does Medtech Have an Appetite for M&A?—Baxter

Article-Does Medtech Have an Appetite for M&A?—Baxter

Does Medtech Have an Appetite for M&A?—Baxter
Baxter's Commentary on M&A

Baxter's Commentary on M&A

"We talk about M&A, and obviously M&A is opportunistic, but transformative M&A is not in the cards as we speak right now. So we're looking at strengthening our current core businesses, and by doing it, we're going to go into adjacencies . . .

As currency weakens in some countries in Latin America, offers an opportunity for potential acquisitions there at a reasonable price, with a good return on investment. . . 

We also will be very diligently looking for partnerships and acquisitions to supplement [the Integrated Pharmacy Solutions] business, because we think there's a great deal of opportunity for the company there as an adjacency."

José Almeida, Baxter chairman, president, and CEO, according to a Seeking Alpha transcript of the company's first quarter earnings call


Get inspired to innovate in medtech at the MD&M East Conference, June 14-16, in New York City. 


Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.